Ming Yan - 09 Apr 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
CHIEF TECHNOLOGY OFFICER, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Issuer symbol
CTKB
Transactions as of
09 Apr 2024
Transactions value $
-$13,304
Form type
4
Filing time
11 Apr 2024, 18:17:17 UTC
Previous filing
19 Mar 2024
Next filing
23 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale -$10.5K -1.5K -0.02% $7.00 6.01M 09 Apr 2024 Direct F1
transaction CTKB Common Stock Sale -$2.8K -400 -0.01% $7.01 6.01M 09 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.